Locations:
This single-port option offers advantages for appropriate patients
Practice changes needed to expand access across academic and community settings
Treatment yields positive results despite late diagnosis and cardiac involvement
Early detection program integrates multiple disciplines to reduce screening barriers and patient anxiety
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Newer class of medications evolves care models for patients with hemophilia
Dotatate PET/CT scan and molecular testing informed treatment trajectory
Learn the latest recommendations in diagnosis, treatment and surveillance
A proactive, framework-based approach
Patients on ibrutinib were more than twice as likely to experience atrial fibrillation or heart failure than those on second-generation alternatives.
Advertisement
Advertisement
Search